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Summary 
Mice harboring a deletion of the gene encoding the transporter associated with antigen presentation-1 
(TAP1)  are impaired in providing major histocompatibility complex (MHC) class I molecules 
with peptides of cytosolic origin and lack stable MHC class I cell surface expression. They conse- 
quently have a strongly reduced number  of CD8 + T  cells.  To examine whether  selection of 
CD8 + T cells is dependent on TAP-dependent peptides, we partially restored MHC class I cell 
surface expression in TAPl-deficient mice by introduction of human 32-microglobulin. We show 
that  selection of functional CD8 § T  cells can be augmented in vivo in the absence of TAP1- 
dependent  peptides. 
C 
D8  T  lymphocytes are positively selected by MHC 
class I molecules to ensure self-restriction, a process that 
requires proper surface expression of MHC class I molecules 
(1). MHC class I molecules present peptides, derived mainly 
from cytosolic proteins, to CD8 + T  cells. Most MHC class 
I molecules rely on these peptides, as provided by the hetero- 
dimeric transporter associated with antigen processing (TAP) 
complex, for efficient  expression at the cell surface (2). Mice 
in which the gene encoding the TAP1 subunit is deleted have 
strongly reduced MHC class I cell surface expression and are 
impaired in positive selection of CD8 + T  cells  (3).  How- 
ever, HLA-A2 can be expressed at intermediate levels on the 
cell surface of TAP-deficient cells, due to its ability to bind 
signal sequence-derived peptides, a TAP-independent source 
of peptides (4). We crossed mice transgenic for HLA-A2 and 
human/~2-microglobulin  (h32m) (TAPI+3A2) onto a TAP1- 
deficient background to examine whether TAP-dependent  pep- 
tides  are  essential  for  development  of CD8 +  T  cells,  or 
whether TAP-independent peptides suffice. We also crossed 
mice transgenic for HLA-B27 and hl32m (TAP1 +  3B27) with 
TAP1--mutant  mice. HLA-B27 is inefficiently expressed at 
the cell surface of TAP-mutant cells (5), and the TAP1-3B27 
mice  were  intended  as  controls.  However,  whereas  only 
HLA-A2 was expressed at the cell surface in a TAPl-deficient 
background,  TAP1-3A2  and TAP1-3B27  mice showed a 
similar  increase in  percentage  of CD8 §  T  cells  compared 
with TAP1-  mice. Rescue of CD8 + T  cells is therefore in- 
dependent of the ability of the transgenic human MHC class 
I  molecules  to bind  signal  sequence-derived peptides  and 
must be due to a feature shared by the transgenic  animals, 
to wit,  the presence of h3zm. 
Materials and Methods 
Mice.  TAPl-deficient mice have been described previously (3). 
HLA-A2/hfl2m-  and HLA-B27/h32m-transgenic  mice have been 
described (6). Mice were kept in the animal facilities of the Mas- 
sachusetts Institute of Technology. Mice 6-10 wk of age were used 
in all experiments. 
Flow Cytometric  Analysis.  The following monoclonal antibodies 
and reagents were used: PA2.1 (HLA-A2) (a gift from Dr. H. N. 
Eisen, Massachusetts Institute  of Technology, Cambridge,  MA); 
ME1 (HLA-B27) (a gift from Dr. J. L. Strominger, Harvard Univer- 
sity, Cambridge,  MA); Y3 (K  b, o~  +  ot2) (American Type Cul- 
ture Collection, Rockville, MD) and B22-249.R1 (D  b, ~x~) (Amer- 
ican Type Culture Collection); PE-coupled anti-CD4, FITC-coupled 
anti CD8-ot,  biotin-coupled  anti-V3  antibodies and PE-coupled 
streptavidin (PharMingen,  San Diego, CA); PE-coupled rat anti- 
mouse Ly-5 (B220) antibody (CALTAG Labs, San Francisco, CA); 
FITC-labeled goat anti-mouse IgG antiserum (Southern Biotech- 
nologies Associates, Birmingham, AL). Single-cell suspensions from 
spleen, lymph nodes, and thymus were prepared, stained, and ana- 
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Mountain View, CA) as described previously (3). Blood was stained 
for CD8-expressing cells with the FITC-coupled anti-CD8  anti- 
body. Red blood cells were subsequently lysed with FACS  |  lysis 
solution (Becton Dickinson &  Co.),  and lymphocytes were ana- 
lyzed on  a  FACScan  | 
Metabolic Labeling and Immunoprecipitations.  Spleen cells were 
cultured for 2 d in DME containing 10% FCS and 2.5 #g/ml Con 
A.  Cells were  incubated  for  30  min  in  methionine-free  RPMI 
medium  and  labeled  with  [3sS]r-methionine/cysteine  (protein 
labeling mix; DuPont/NEN,  Boston, MA) for the indicated time 
and, where appropriate, chased in presence of 1 mM cold t-meth- 
Figure  1.  Cell surface expression and intracellular transport of MHC class I molecules in TAP1- BA2 and TAP1- ~B27 mice. (aft) Flow cytometric 
analysis of Ly5- splenocytes of indicated mice with monoclonal antibodies against (a) HLA-A2, (b) HLA-B27, (c and d) H-2K  b, and (e and f) H-2D  b. 
(g) Metabolic labeling of splenocytes from TAP1  +/$B27 and TAP1-~B27 mice. Lysates were prepared and B27 complexes were immunoprecipitated 
with mAb W6/32 and flee B27 heavy chains with a rabbit antiserum raised against free human heavy chains.  Immunoprecipitates were analyzed on 
a  1D-IEF gel. (h) Pulse-chase analysis on splenocytes from TAP1 ~  BA2, TAP1-~A2, TAP1 ~, and TAP1-  mice. Cells were labeled for 15 min and 
chased for 2 h. H-2  b complexes were immunoprecipitated with a conformation-dependent rabbit antiserum raised against purified H-2  b molecules and 
analyzed on 1D-IEF gels. (i) Steady-state distribution of K b molecules in thymic capsule extracts from TAP1 +~A2, TAP1 -/3A2, TAP1 +, and TAP1  -  mice. 
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Figure 2.  Positive  selection of CD8 +  T  cells in  TAPI-~A2 and 
TAP1-j[~B27 mice. (a)  CD8+  cells in  the  thymus  of TAPI-~A2, 
TAP1+  BA2, TAP1-, and TAP1  + mice. The percentage of CD8 + thymo- 
cytes is indicated in the lower right corner of each plot. (b) Percentage 
ofCDS+ T cells in blood. Mean _+ SD (left to right): 11.94 _+  1.96; 10.41 
_+  1.19; 10.41 _+  3.59; 0.48 _+  0.14; 2.83 _+ 0.82; and 3.24 +_ 0.73. (c) 
The population of CD8 + T calls in lymph nodes from TAP1- ~A2 mice 
is polyclonal.  CD8 + T cells from three individual TAP1  -~A2 mice (white 
bars) and a TAPI+~A2 mouse (black bars) display all the TCR V~ seg- 
ments tested for. 
ionine and T.-cysteine. Cells were lysed in NP-40 lysis mix (0.5% 
NP-40,  50 mM Tris,  pH 7.4,  5  mM  MgC12,  0.1  mM  PMSF). 
Immunoprecipitations, neuraminidase digestion, and one-dimen- 
sional isoelectric focusing (1D-IEF) were performed as previously 
described (7). 
Steady State Distribution of K b Molecules in the Thymus.  Thymuses 
were isolated from 6-8-wk-old mice. Thymocytes were removed 
by gently squeezing the thymic lobes with forceps and rinsing with 
PBS. The remaining capsule was macerated and dissolved in IEF 
sample buffer by repeated  shearing through  a  25Gll/2  needle. 
Samples were separated on 1D-IEF and blotted to nitrocellulose 
paper. The blot was incubated with a rabbit antiserum raised against 
a peptide derived from the cytoplasmic tail of K s (~p8) followed 
by  a  horseradish peroxidase-coupled goat  anti-rabbit antibody 
(Amersham, Arlington Heights, I1,). Bound antibody was detected 
by a chemiluminescence detection kit (Amersham) and exposure 
to films (X-OMAT AR; Eastman-Kodak Co.,  Rochester, NY). 
Stability  Assay.  Freshly isolated spleen cells were labeled by 
lactoperoxidase-catalyzed  iodination (see reference 18). Cells were 
lysed in 2 ml NP-40 lysis mix. L~ates were divided into four equal 
parts and were incubated for 15 min on ice after addition of 0.5 
ml lysis mix with or without 60 #M YAPGNFPAL peptide. Samples 
were kept on ice or incubated at 39~  for 45 min. Lysates were 
precleared twice, followed by immunoprecipitation of H-2  b corn- 
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from Dr. S. Nathenson, Albert Einstein College of  Medicine, Bronx, 
NY).  Immunoprecipitates  were analyzed by 12.5% SDS-PAGE. 
Peptide-binding  Assay. YAPGNFPAL  peptide was labeled by chlo- 
famine T-catalyzed iodination  (see reference 11). 106 splenocytes 
were incubated in PBN buffer (PBS +  1% BSA +  0.01% NAN3) 
with the indicated concentrations of 12sI-YAPGNFPAL for 1 h at 
23~  Cells were lysed in NP-40 lysis mix containing 100 #M cold 
FAPGNYPAL. Lysates were precleared once, and K  b molecules 
were precipitated with the c~p8 serum. Immunoprecipitates were 
counted in a 3/counter. Values are the mean of triplicates. 
Results. 
Spleen cells from TAP1-BA2 mice were stained with an 
mAB directed against HLAoA2. They express an intermediate 
level of HLA-A2 on the cell surface (Fig.  1 a) compared with 
cells from TAPI+3A2 mice. This is in agreement with ob- 
servations on TAP-deficient cell lines (8). The cell surface ex- 
pression of HLA-A2 is paralleled by an approximately two- 
fold higher percentage of CD8 §  cells  in the thymus (Fig. 
2  a)  and  an  approximately  sixfold  higher  percentage  of 
CD8 + T  cells  in blood (Fig.  2  b) in TAP1-3A2 mice,  as 
compared with TAP1-  mice. 
HLAoB27 cannot be detected either at the cell surface in 
TAPl-deficient animals, in contrast to HLA-A2 (Fig.  1 b). A 
3-h metabolic labeling of TAP1-3B27 spleen cells followed 
by immunoprecipitation with the conformation-dependent 
antibody W6/32 and analysis of the immunoprecipitates on 
a 1.D-IEF gel shows that a substantial fraction of the HLA- 
B27 molecules fail to assemble with fl2m (Fig.  I g). Parallel 
immunoprecipitation with an antiserum raised against dena- 
tured free heavy chains reveals that most B27 molecules are 
present as free heavy chains (Fig.  1 g). The few complexes 
that are present do not carry sialic acids,  the acquisition of 
which is indicative of proper intracellular transport. These 
data underscore the reliance of HLA-B27 on TAP for a suit- 
able source of peptides required for assembly and surface ex- 
pression. Nonetheless, the TAPl-flB27 mice show a similar 
increase in the percentage of CD8 + T cells in the periphery, 
as do the TAP1-3A2 mice (Fig.  2  b). 
By examination of the surface expression of H-2K  b and 
D b, this paradox may be satisfactorily explained. Surface ex- 
pression  of H-2K  b and  D b class  I  molecules in  a  murine 
TAP2-deficient cell line can be increased by transfection of 
this cell line with hfl2m (5). Indeed, K b shows a fivefold and 
D b a twofold increase in cell surface expression on spleen 
cells  from both  TAPI-flA2 and  TAP1-3B27  mice com- 
pared with TAP1-  mice (Fig.  1, c-f).  Pulse-chase analysis 
shows that these K b and D b heavy chains preferentially as- 
sociate  with hfl2m and  are transported to the cell surface, 
as judged also  by acquisition of sialic acids  (Fig.  1 k). 
Relative levels of MHC class I  surface expression in the 
thymus were determined at steady state.  Thymic lobes were 
depleted of thymocytes, and extracts of the remaining thymic 
capsules were resolved on 1D-IEF and analyzed by immuno- 
blotting. In TAP1- animals, the majority of K  b heavy chains 
remains unmodified (Fig.  1 i), but in TAPI-flA2 animals 
(and TAP1-fiB27 animals,  data not shown) modification of 
K b  is  observed,  indicating  that  the  K b  molecules  have 
Figure  3.  Stability  and peptide  binding capacity  of  MHC class I mole- 
cules. (a) Stabilization  of H-2  b molecules  by the YAPGNFPAL  peptide. 
Cell lysates  of  cell surface-labeled  spleen  cells  from  the indicated  mice  were 
preincubated with (+) or without (-) 30/~M YAPGNFPAL  and subse- 
quently  kept at 4~  or 39~  H-2  b molecules  were then immunoprecip- 
itated with the conformation-dependent  anti-H-2  b serum and analyzed 
by SDS-PAGE. (b) Relative  t2sI-YAPGNFPAL  peptide-binding  capacity  of 
K  b molecules  on the cell surface  of TAP1-  flA2, TAP1  +  3A2, TAP1-, and 
TAP1+ cells. YAPGNFPAL peptide was used for iodination instead of 
FAPGNYPAL to prevent rapid dissociation of bound peptide from the 
MHC class I complex  caused  by iodination  of the tyrosine  anchor  residue 
(14). 
790  Modulation  of Positive Selection in TAP1 Mutant Mice traversed the trans-Golgi network. Thus both in the periphery 
and in the thymus, surface expression of endogenous MHC 
class I molecules is increased in the presence of h32m.  This 
increase in MHC expression may explain selection of CD8 + 
T  cells in the TAP1-3A2  and TAP1-3B27 mice. 
We examined polyclonality of the CD8 + T  cell popula- 
tion  present  in  TAP1-3A2  mice.  Cell  suspensions,  made 
from  lymph  nodes  of TAPI-BA2  and  TAPI+BA2  mice, 
were stained with antibodies against CD8 and different TCR 
V3 chains.  Of all the V3 chains tested, those used by CD8 + 
T  cells in TAPI+3A2 mice are also used by CD8 + T  cells 
in TAP1- 3A2 mice, indicating that the CD8 + T cell popu- 
lation  in  TAP1-3A2  mice is polyclonal  (Fig.  2 c).  These 
CD8 + T  cells are able to respond in a primary mixed lym- 
phocyte reaction.  After  5  d  of culture,  strong  CD8  '§  T 
ceU-dependent cytotoxicity against H-2 a targets is observed, 
similar  to that  in TAPI+~A2  mice (data  not  shown). 
MHC molecules from TAP-deficient cells (9-11) and mice 
(3) have been proposed to be devoid of peptide based on their 
failure to be expressed efficiently at the cell surface, their ther- 
molability, and their increased peptide-binding capacity.  Do 
MHC class I molecules in TAP1-3A2 mice display similar 
properties? Detergent lysates of cell surface-iodinated spleen 
cells were incubated at 4~  or 39~  in the presence or ab- 
sence of the 9-mer peptide YAPGNFPAL, a variant  of the 
Sendai virus peptide FAPGNYPAL (12, 13) that contains the 
anchor residues for both K b and D b. H-2  b class I complexes 
were then immunoprecipitated with a conformation-specific 
anti H-2  b serum. Labeled MHC dass I complexes are absent 
from lysates of TAP1-  cells, but they are detected in lysates 
from TAP1-3A2 cells (Fig. 3 a) in amounts in accordance 
with the data obtained by flow cytometric analysis  (Fig.  1, 
c and e).  Exposure of lysates of TAP1-3A2  cells  to 39~ 
results in a strong decrease in reactivity with the conformation- 
specific anti H-2  s antiserum, but addition of YAPGNFPAL 
peptide prevents thermal  unfolding  of the H-2  s molecules 
(Fig.  3 a).  No such loss of immunoreactive material  is ob- 
served in extracts from TAP1 + and TAP1 +3A2 cells. 
To determine  the pool size of K b molecules on the cell 
surface that are available for binding dass I peptides, a peptide- 
binding assay was performed on freshly isolated splenocytes 
by use of radiolabeled  12sI-YAPGNFPAL.  K s molecules on 
splenocytes from both TAP1-  and TAP1-3A2  mice bind 
considerably more t2sI-YAPGNFPAL than K b molecules on 
TAP1 + and TAP1 +3A2 cells (Fig. 3 b), despite lower levels 
of K b call  surface expression (Fig.  1 c).  An approximately 
twofold difference in binding capacity between TAP1-3A2 
and TAP1-  cells is observed, whereas TAP1-3A2 cells ex- 
press approximately fivefold more K s molecules on the cell 
surface.  A  significant  proportion  of  K s  molecules  on 
TAP1-3A2  cells  may  have  bound  peptides  from  a  TAP- 
independent source (15). These peptides presumably bind with 
a lower affinity than TAP-dependent peptides, since they fail 
to stabilize H-2  s complexes in vitro (Fig.  3 a). 
Discussion 
In both ~zm-  and TAP1 -  mice, small numbers of CD8 + 
T  cells are present  that  can be expanded in vivo and vitro 
(16-19).  Our data show that  selection of CD8 + T  cells in 
TAP1-  mice can be augmented  in vivo by increasing  cell 
surface expression of H-2K  b and D b through heterodimeri- 
zation  with  h32m.  In  vivo  selection  of CD8 +  T  cells  is 
therefore not strictly dependent on peptides of cytosolic origin 
and can be mediated by MHC class I molecules that are ei- 
ther  devoid of peptide,  have bound peptides from a TAP- 
independent  source,  or both.  The  pool of CD8 + T  cells 
selected by these molecules is polyclonal and alloreactive. 
In fetal thymic organ cultures (FTOCs), an in vitro model 
for thymic  selection, peptides contribute to the spedficity 
of positive selection (20-23). In FTOCs derived from 32m- 
mice, cell surface expression of MHC class I molecules is not 
detectable, and structural similarity between the selecting pep- 
tide and the nominal  antigen is required for positive selec- 
tion  of  a  monoclonal  T  cell  population  beating  a  K b- 
restricted, ovalbumin-specific TCR (22). Selection in TAP1- 
FTOCs  of a  Db-restricted  lymphocytic  choriomeningitis 
virus  peptide-specific  T  cell can  be  accomplished  by the 
nominal antigen at low peptide concentrations (30/xM) (23). 
However, at a 10-fold higher peptide concentration, and there- 
fore at much higher MHC class I density (21),  the same T 
cell  can  be  selected  by  a  DS-binding  peptide  (influenza 
NP366-374) structurally unrelated to the nominal antigen. 
At physiological densities of MHC dass I/peptide complexes, 
selection of a given CD8 § T  cell may be less dependent on 
a specific peptide and may be accomplished by MHC class 
I molecules bearing a heterogeneous set of peptides not neces- 
sarily related to the nominal antigen other than by their ability 
to bind to  the restriction  element in question. 
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